Schedule 13G ownership disclosure

Tonix Pharmaceuticals Holding Corp

Common Stock · CUSIP: 890260839

Event date: 2025-09-30

Filing-level shares
556,957
Percent of class
6.35%
  • The Vanguard Group

    Shares: 556,957 · Class: 6.35%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000328
Form type
SCHEDULE 13G
Filer
Tonix Pharmaceuticals Holding Corp.
CIK
CIK 1430306
Filed
Oct 31, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub